Study of HS-20117-2 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests an investigational medicine called HS-20117-2 for people with advanced solid tumors that haven't responded to other treatments. The goal is to see if it is safe and if it might help shrink or control the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your cancer has at least one measurable tumor (by standard imaging).
- You are still able to take care of yourself (ECOG performance status 0 or 1).
- Your heart, blood sugar, blood pressure, and other major health conditions are stable and not severely out of control.
- You have not had major bleeding, blood clots, or serious infections recently.
- You are willing to practice effective contraception or not plan to have children during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called HS-20122 in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective.
This trial tests a new combination treatment called HS-20089 for people with advanced solid tumors. The goal is to see if it is safe and how well it works against cancer that has not responded to other treatments.
This trial tests an experimental drug called HRS-3802 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and how the body processes it.
This trial is testing an experimental drug called HS-20197 for people with advanced solid tumors (cancers that have spread or can't be removed). The goal is to see if it's safe and how well it works for a variety of solid tumor types.
This trial is testing a new drug called HS-20105, given by injection, for people with advanced solid tumors that have stopped responding to standard treatments. The drug targets a protein on cancer cells to try to slow or stop their growth.
This trial tests a new drug, HS-20117, for people with advanced solid tumors, especially certain types of lung cancer. It aims to see if the drug is safe and effective when other treatments have stopped working.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.